M A Lumsden

No ORCID on file · 1 paper in corpus
article 1990
Fertility and sterility ·doi:10.1016/s0015-0282(16)53217-8

Ten endometriosis patients received luteinizing hormone releasing hormone (LH-RH) agonist (buserelin) implant injections (6.6 mg subcutaneously) at days 0, 42, 84 and 126. Serum LH and follicle-stimulating hormone (FSH) were lowered by day …